Citigroup
HZNP

Citigroup’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Citigroup’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,500
Closed -$289K – 5972
2023
Q3 		$289K Hold
2,500
– – ﹤0.01% 3433
2023
Q2 		$257K Buy
+2,500
New +$264K ﹤0.01% 3768
2021
Q1 		– Sell
-36,100
Closed -$2.64M – 7893
2020
Q4 		$2.64M Buy
36,100
+6,200
+21% +$461K ﹤0.01% 2589
2020
Q3 		$2.32M Sell
29,900
-5,700
-16% -$392K ﹤0.01% 2517
2020
Q2 		$1.98M Buy
35,600
+10,600
+42% +$453K ﹤0.01% 2818
2020
Q1 		$741K Buy
25,000
+10,600
+74% +$359K ﹤0.01% 3490
2019
Q4 		$521K Sell
14,400
-6,200
-30% -$190K ﹤0.01% 4386
2019
Q3 		$561K Buy
20,600
+7,200
+54% +$186K ﹤0.01% 4236
2019
Q2 		$322K Buy
13,400
+9,800
+272% +$249K ﹤0.01% 4860
2019
Q1 		$95K Sell
3,600
-3,300
-48% -$78.2K ﹤0.01% 5794
2018
Q4 		$135K Sell
6,900
-4,300
-38% -$84.3K ﹤0.01% 5403
2018
Q3 		$219K Sell
11,200
-19,500
-64% -$371K ﹤0.01% 5158
2018
Q2 		$508K Buy
30,700
+19,100
+165% +$291K ﹤0.01% 4088
2018
Q1 		$165K Sell
11,600
-2,900
-20% -$42.8K ﹤0.01% 5165
2017
Q4 		$212K Sell
14,500
-14,200
-49% -$199K ﹤0.01% 4983
2017
Q3 		$364K Sell
28,700
-1,700
-6% -$21.6K ﹤0.01% 4423
2017
Q2 		$361K Buy
30,400
+10,100
+50% +$126K ﹤0.01% 4297
2017
Q1 		$300K Sell
20,300
-72,700
-78% -$1.18M ﹤0.01% 4304
2016
Q4 		$1.5M Buy
93,000
+39,100
+73% +$709K ﹤0.01% 3259
2016
Q3 		$977K Buy
53,900
+13,300
+33% +$260K ﹤0.01% 3249
2016
Q2 		$669K Sell
40,600
-22,500
-36% -$364K ﹤0.01% 3335
2016
Q1 		$1.05M Buy
63,100
+14,200
+29% +$248K ﹤0.01% 3282
2015
Q4 		$1.06M Buy
48,900
+8,300
+20% +$162K ﹤0.01% 3073
2015
Q3 		$805K Buy
40,600
+36,400
+867% +$1.15M ﹤0.01% 3307
2015
Q2 		$146K Buy
+4,200
New +$128K ﹤0.01% 4709

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's HZNP Position: Q4 2023 in Review

Citigroup sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 350,151 shares — an estimated $40.5M sold.

Citigroup first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $42.4M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Citigroup reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Citigroup sold 350,151 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.5M.
  • Citigroup first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • Citigroup's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $42.4M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Citigroup's 13F filing for Q4 2023, filed 9 Feb 2024.